drugset
Drugs / Adezunap
last change Dec 2024 re-read 3 minutes ago

Adezunap

also known as AP707

Other / unclassified

Developed for
chronic pain syndrome · neuralgia · neuropathy, painful · diabetic polyneuropathy · nerve plexus disorder · pain agnosia · peripheral nerve lesion · traumatic neuropathy
Investigated by
Apurano Pharmaceuticals GmbH

Trials 8

today NCT06072560 · Ph 3 NCT06071949 · Ph 3 NCT06071975 · Ph 3 NCT06072573 · Ph 3 NCT06071962 · Ph 3 NCT06072001 · Ph 3 NCT06071936 · Ph 3 NCT06071988 · Ph 3
202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT06072560 Nov 2023 → Sep 2024 chronic pain syndrome Apurano Pharmaceuticals GmbH Unknown No outcome recorded
Phase 3 NCT06071949 Nov 2023 → Sep 2024 chronic pain syndrome, multiple sclerosis, neuropathy, painful, paraplegia +2 Apurano Pharmaceuticals GmbH Unknown No outcome recorded
Phase 3 NCT06071975 Nov 2023 → Sep 2024 chronic pain syndrome, diabetes mellitus, diabetic polyneuropathy, neuralgia Apurano Pharmaceuticals GmbH Unknown No outcome recorded
Phase 3 NCT06072573 Nov 2023 → Sep 2024 chronic pain syndrome, diabetes mellitus, diabetic polyneuropathy, neuralgia +1 Apurano Pharmaceuticals GmbH Unknown No outcome recorded
Phase 3 NCT06071962 Nov 2023 → Sep 2024 chronic pain syndrome Apurano Pharmaceuticals GmbH Unknown No outcome recorded
Phase 3 NCT06072001 Nov 2023 → Sep 2024 chronic pain syndrome, multiple sclerosis, neuropathy, painful, paraplegia +2 Apurano Pharmaceuticals GmbH Unknown No outcome recorded
Phase 3 NCT06071936 Nov 2023 → Sep 2024 chronic pain syndrome, nerve plexus disorder, neuralgia, neuropathy, painful +1 Apurano Pharmaceuticals GmbH Unknown No outcome recorded
Phase 3 NCT06071988 Nov 2023 → Sep 2024 chronic pain syndrome, nerve plexus disorder, neuralgia, neuropathy, painful +1 Apurano Pharmaceuticals GmbH Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as Adezunap ClinicalTrials.gov intervention name — accepted as the source's own label NCT06071936 ↗
7

NCT06072001 ↗

NCT06072560 ↗

NCT06072573 ↗

NCT06071988 ↗

NCT06071962 ↗

NCT06071975 ↗

NCT06071949 ↗
Known as AP707 “Based on previous findings indicating the pain modulating effects of cannabinoids in chronic pain disorders, this clinical trial investigates the efficacy and tolerability of...” NCT06071949 ↗
7

“Drug: Adezunap (AP707)” NCT06071962 ↗

“Drug: Adezunap (AP707)” NCT06072001 ↗

“Adezunap (AP707)” NCT06071936 ↗

“Adezunap (AP707)” NCT06071975 ↗

“Adezunap (AP707)” NCT06071988 ↗

“Adezunap (AP707)” NCT06072560 ↗

“Adezunap (AP707)” NCT06072573 ↗
Modality Other / unclassified “THC-focused nano endocannabinoid system modulator AP707” NCT06071962 ↗
Route Other “Sublingual spray” NCT06071936 ↗